CipherBio Weekly Digest, Feb 17 – Feb 23, 2022 brings you over $2.B in life science deals.
$2.96B in Life Science Funding
CipherBio Weekly Digest: Week of Feb 10 – Feb 16, 2022 This…
We Added 70 Companies and over 120 Funding Events
$2.77B in deals, $391.90M in Series A, 70 companies and 29 investors added to our CipherBio platform.
Funding Products and Clinical Phases
CipherBio Weekly Digest of the week of Jan 27 – Feb 2, 2022: $1.77B in deals, $421M in Series A, 40 new companies added to CipherBio.
$1.7B in Deals and 136 New Funding Events
CipherBio Weekly Digest: Week of Jan 20 – 26 2022 This week…
This Week $5.74B in Deals and 91 New Life Science Companies
CipherBio Weekly Digest: Week of Jan 13 – 19 2022 This week…
$11.4B for Cardiovascular Disease in Medical Devices
CipherBio PRO Cardiovascular Disease Insight explores the most targeted condition area for…
81 Digital Therapeutics Companies Received $3.1 Billion From 302 Investors
Digital therapeutics are quickly rising in popularity, with the advancement of technology…
183 Immuno-Oncology Companies Raised $46 Billion
Attempts to harness the immune system to fight cancer date back to the late 1800s. It has been less than 40 years since the first of these immuno-oncology therapies demonstrated success and obtained approval. Since then, nearly 40 cancer immunotherapies have received FDA approval.
$18 Billion Invested in 135 Cell Therapy Companies
Cell therapy was born in the 1930s when Paul Niehans earned the…